Cipla Ltd 04 Nov 2026 12:00 AM
Cipla appoints Vikram Janakiraman as Global Chief Technical Operating Officer, effective December 2026,
Cipla Ltd. announced the appointment of Mr. Vikram Janakiraman as Global Chief Technical Operating Officer, effective December 7, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited on November 4, 2026. Mr. Janakiraman joins Cipla from the Boston Consulting Group (BCG), where he was a Managing Director and Senior Partner, and previously held leadership positions at Glenmark Pharmaceuticals.
Cipla Ltd 28 Oct 2026 12:00 AM
Cipla Ltd consolidated sales up 4.11% on year in Q3FY2026, net profit inched up 8.82%,
Cipla Ltd share price slipped 0.22% to Rs 1350.0. The Company`s net profit saw a mild growth of 8.82% to Rs 856.52 crore, while revenue from operations slightly gained 4.11% to Rs 7368.15 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.44 lakh crore, gaining 4.06%. It has marginally improved by 3.17% over last one week and eased lower by 0.26% in last one month while the market capitalization of Cipla Ltd has improved by 2.76% and 7.91% in the same period respectively. Profit before tax (PBT) of Cipla Ltd stood at Rs 1177.34 crore in Q3 FY26, tumbling by 36.48% year-on-year, and rising 8.82% quarter-on-quarter. EBITDA came in at Rs 1237 crore, tanking 23.94% YoY and rallying 26.01% sequentially. Total expenses grew marginally by 2.08% to Rs 6361.01 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1523.74 crore, increasing 12.29% YoY, while employee benefits expense was at Rs 1474.61 crore, seeing a marginal contraction of 1.52% YoY. For the TTM ended FY26, revenue from operations posted a slight growth of 2.09% to Rs 27711.69 crore, while net profit witnessed a sharp fall of 26.86% to Rs 3869.79 crore, compared to previous TTM. EBITDA surged by 636906% to Rs 5000.89 crore, and PBT tumbled by 23.42% to Rs 5223.63 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 3940.02 crore in FY26, as against Rs 5004.98 crore in FY25. Cipla Ltd crashed 14.77% in last one year, significantly underperforming the benchmark BSE Sensex which has slipped by 13.19% during the same period.
Cipla Ltd 27 Oct 2026 12:00 AM
Cipla Ltd consolidated sales up 4.11% on year in Q3FY2026, net profit saw a marginal increase of 8.82%,
Cipla Ltd share price gained 1.20% to Rs 1353.0 after the company`s net profit grew slightly 8.82% to Rs 856.52 crore, while revenue from operations improved marginally 4.11% to Rs 7368.15 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, rising 3.34%. It has marginally improved by 0.07% over last one week and softened by 3.01% in last one month while the market capitalization of Cipla Ltd has improved by 1.65% and 8.17% in the same period respectively. Profit before tax (PBT) of Cipla Ltd stood at Rs 1177.34 crore in Q3 FY26, plunging by 36.48% year-on-year, and gaining 8.82% quarter-on-quarter. EBITDA came in at Rs 1237 crore, tumbling by 23.94% YoY and expanding by 26.01% sequentially. Total expenses inched up 2.08% to Rs 6361.01 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 1523.74 crore, going up by 12.29% YoY, while employee benefits expense was at Rs 1474.61 crore, slipping by 1.52% YoY. For the TTM ended FY26, revenue from operations inched higher 2.09% to Rs 27711.69 crore, while net profit plunged by 26.86% to Rs 3869.79 crore, compared to previous TTM. EBITDA surged by 636906% to Rs 5000.89 crore, and PBT tanked by 23.42% to Rs 5223.63 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 3940.02 crore in FY26, as against Rs 5004.98 crore in FY25. Cipla Ltd tumbled by 14.58% in last one year, significantly underperforming the benchmark BSE Sensex which has reduced by 13.18% during the same period.
Cipla Ltd 27 Oct 2026 12:00 AM
Cipla’s board approved Rashmi Joshi as an independent director for five years,
Cipla Ltd. announced that its board of directors approved the appointment of Ms. Rashmi Joshi as an additional and independent director for a period of 5 years, effective October 27, 2026, subject to shareholder approval. Ms. Joshi’s appointment is for the period October 27, 2026, to October 26, 2031, and she brings over three decades of experience across various sectors, including pharmaceuticals, and has previously served on the boards of Godrej Industries Limited and Castrol India Limited, among others.
Cipla Ltd 26 Aug 2026 12:00 AM
Cipla Ltd.`s committee approved equity share allotments under employee stock schemes,
Cipla Ltd. announced that its Operations and Administrative Committee has allotted 5,281 fully paid-up equity shares of INR 2 each under the Employee Stock Option Scheme 2013 -A and the Cipla Employee Stock Appreciation Rights Scheme 2021, increasing the company’s issued, subscribed and paid-up share capital to INR 1,61,57,16,894 comprising of 80,78,58,447 equity shares.
Subscribe for our
newsletter
Open Account Now